CollPlant Biotechnologies (CLGN) Share-based Compensation (QoQ) (2018 - 2025)
CollPlant Biotechnologies (CLGN) Share-based Compensation (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | CollPlant Biotechnologies | 4.13 Mn | 4.13 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 614.89% |
| Sep 30, 2025 | -20.79% |
| Dec 31, 2024 | -685.24% |
| Sep 30, 2024 | 4.67% |
| Jun 30, 2024 | 69.66% |
| Mar 31, 2024 | -48.58% |
| Dec 31, 2023 | 208.25% |
| Sep 30, 2023 | -138.14% |
| Jun 30, 2023 | 165.76% |
| Mar 31, 2023 | 17.08% |
| Dec 31, 2022 | -35.44% |
| Sep 30, 2022 | -55.15% |
| Jun 30, 2022 | 428.85% |
| Mar 31, 2022 | -267.64% |
| Dec 31, 2021 | -25.27% |
| Sep 30, 2021 | -21.54% |
| Jun 30, 2021 | -3.30% |
| Mar 31, 2021 | 142.40% |
| Dec 31, 2020 | -206.70% |
| Sep 30, 2020 | -178.20% |